🔎 Trials Near Me

Почетна › Лимфом › Misuri

Kliničke studije za Лимфом u državi Misuri

17 studija za Лимфом traži učesnike na lokacijama u državi Misuri.

Gradovi u državi Misuri

Zvanični tekst studije (na engleskom)

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • Washington University School of Medicine, St Louis
  • и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04301076

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

  • Washington University School of Medicine in St. Louis, St Louis
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07015242

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

  • St. Luke's Hospital, Chesterfield
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06084936

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  • Kansas City VA Medical Center, Kansas City, MO, Kansas City
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 30. 10. 2026. · NCT06520098

Collection of Tissue Samples for Cancer Research

  • Washington University - St. Louis, St Louis
Тражи се учесникОпсервациона студија
2 Months · Оба пола · Ажурирано 27. 10. 2026. · NCT00900198

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

  • Washington University School of Medicine/Siteman Cancer Center, St Louis
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT06528301

An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers

  • Washington University School of Medicine, St Louis
Тражи се учесник
Узраст од 18 до 99 · Оба пола · Ажурирано 8. 10. 2026. · NCT07226934

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • Washington University School of Medicine - Oncology Hospital - Public, St Louis
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07192471

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Washington University School of Medicine in St. Louis, St Louis
Тражи се учесникФаза 1/2
До 25 година · Оба пола · Ажурирано 25. 9. 2026. · NCT04094610

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • Children's Mercy Hospitals and Clinics, Kansas City
  • Washington University School of Medicine, St Louis
Тражи се учесникФаза 1/2
12 Months – 21 Years · Оба пола · Ажурирано 11. 9. 2026. · NCT04870944

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

  • Washington University School of Medicine, St Louis
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 9. 2026. · NCT07082803

DALY II USA/ MB-CART2019.1 for DLBCL

  • Washington University, St. Louis, St Louis
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 13. 7. 2026. · NCT04792489

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Washington University School of Medicine, St Louis
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 18. 5. 2026. · NCT01790152

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

  • Saint Louis University, St Louis
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 4. 2026. · NCT03823534

BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma

  • Washington University, St Louis
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 20. 2. 2026. · NCT06854003

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

  • Lake Regional Hospital, Osage Beach
Тражи се учесникФаза 3Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 13. 1. 2026. · NCT05006482

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

  • Washington University, St Louis
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 14. 11. 2025. · NCT05643742

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.